Navigation Links
CSSi, the Leader in Global Patient Recruitment Solutions for Clinical Trials Industry, Rolls Out Redesigned Website: www.CSSiEnroll.com
Date:1/9/2014

GLEN BURNIE, Md., Jan. 9, 2014 /PRNewswire/ -- CSSi, the leader in global patient recruitment solutions for the clinical research industry, is proud to announce the launch of its redesigned website, www.CSSiEnroll.com. The new site reflects the evolution of the company from focusing on site performance to a global patient recruitment provider motivated to provide innovative enrollment solutions to sponsors and CROs for clinical trials.

The fusion of style and content provides enhanced details for sponsor companies, CROs and investigative sites who are seeking targeted data on CSSi's strategic and innovative services; these services range from patient recruitment campaign strategies to full-service enrollment planning, including study start-up, creative design, media planning and digital messaging.  

Clients will also find information on Local Enrollment Specialists™ (LES™), a proprietary and unique service offering of CSSi, which is a key element of their successful global recruitment programs. The CSSi LES™ team members are located in over 40 countries and on every continent. They are experienced in patient recruitment, have a strong knowledge of local ethics committees and regulatory bodies, and speak the local language of the sites which they are supporting.

"CSSi has been an integral part of the patient recruitment industry for quite a while, and we have always stood out by offering more than just recruitment services," stated Chris Trizna, President. "Take a look at our case studies," added Trizna. "Our clients can see where CSSi's involvement has a unique ability to positively impact enrollment, not just responses, referrals or recruitment."

Trizna further elaborated, "The re-launching of the CSSi website is the next step in the growth of our company and gives us a platform to highlight our unique products, services, and client relationships during this exciting time of growth and development. CSSi is significantly more than a recruitment and site performance company--- we are truly a full-service, global patient enrollment solutions organization and our new website represents an important step in allowing us to communicate our scope and significance to the clinical trial industry."

www.CSSiEnroll.com 
6958 Aviation Blvd., Suite H, Glen Burnie, MD 21061 | Phone:  866.277.4888 | Fax 410.553.0087

About CSSi

CSSi delivers global patient recruitment solutions that ensure successful enrollment, on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. For more information on CSSi, visit www.CSSiEnroll.com, or contact Jennifer Whitlock via email or 443-308-5803.

Read more news from CSSi.

 


'/>"/>
SOURCE CSSi
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. A Unique Collaboration of Life Science Leaders, including the Fight Against Cancer Innovation Trust, MaRS Innovation Ventures Trust and MaRS Phase II Investment Trust, has formed Triphase Accelerator Corporation to be an Oncology Development Accele
2. Schneider Electric reinforces its position as a leader in solar utility scale market
3. EY Global Life Sciences Center Announces New Appointments to Its Leadership Team
4. Bioentrepreneurship Leader Joins UM Ventures Team
5. Intrexon Strengthens Leadership in Companys Rapidly Growing Health Sector
6. Five Key Mega Trends in Nature Inspired Innovation: A Thought Leadership Video by Dr. Sanjay Mazumdar
7. Excelera Corp. Announces Commitments by National Leaders
8. Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs
9. Everest Group Recognizes TCS as a Global Leader and Star Performer in Life Sciences IT Outsourcing
10. Genelux, a Leader in the Emerging Oncolytic Virotherapy Field, Receives Significant Industry Honor from Elsevier Business Intelligence, Identifying GL-ONC1 as One of 2013s Top Oncology Projects to Watch
11. BioSpace Spotlights Washington State Biotech Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... , March 23, 2017 Kineta, ... development of novel therapies in immuno-oncology, today announced ... lead" small molecule compounds that activate interferon response ... pathways and demonstrate immune-mediated tumor regression in a ... the study who demonstrated complete tumor regression to ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ... strategic partnerships and joint development activities. , “Dr. Floyd’s career has spanned 30 ...
(Date:3/22/2017)... , March 22, 2017 Good Start ... it has eclipsed the 130 million covered lives mark ... Shield of Texas . With newly ... Company continues to enjoy strong payor acceptance based on ... clinical programs and genetic counseling, its industry-leading customer care ...
Breaking Biology Technology:
(Date:3/22/2017)... Calif. , March 21, 2017 ... analytics company serving law enforcement agencies, announced today the ... as director of public safety business development. ... diversified law enforcement experience, including a focus on the ... In his most recent position, Mr. Sheridan served as ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/2/2017)... March 2, 2017 Summary This report ... and its partnering interests and activities since 2010. ... Read the full ... Alliance since 2010 report provides an in-depth insight into the ... companies. On demand company reports are prepared upon ...
Breaking Biology News(10 mins):